Method for preparing ovarian cancer target ferroferric oxide nano-particle at room temperature
A technology of ferric tetroxide and ovarian cancer, applied in the direction of iron oxide/iron hydroxide, nanotechnology, nanotechnology, etc., can solve the problems of inability to obtain biologically active surface components and structures, destruction of polypeptide biological activity, harsh conditions, etc. To achieve the effect of environmental friendliness of products and improve biocompatibility
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0019] Dissolve 5.3g ferric chloride hexahydrate and 1.98g ferrous chloride tetrahydrate in 25ml hydrochloric acid solution, stir and mix with a magnetic stirrer for 15 minutes, then add 5mg polypeptide solution to the above solution, continue stirring for 30 minutes, and The dispersion was put into a stoppered Erlenmeyer flask and left at room temperature for 24 hours. Disperse 15g of sodium hydroxide in 250mL of secondary water, stir and mix evenly. At a temperature of 25° C. and a stirring speed of 300 rpm, 250 mL of the above sodium hydroxide aqueous solution was added dropwise to the iron salt and polypeptide solution. Continue stirring at a speed of 300 rpm for 2-6 hours to facilitate the full reaction of the solution. Afterwards, the mixed system was left to stand at room temperature for 2 days to facilitate the nucleation and growth of ferric oxide nanoparticles. The final product is obtained by washing and centrifugation. During the centrifugation process, the reac...
Embodiment 2
[0021] Dissolve 5mg of polypeptide, 5.3g of ferric chloride hexahydrate and 1.98g of ferrous chloride tetrahydrate in 25ml of hydrochloric acid solution, stir and mix with a magnetic stirrer for 15 minutes; disperse 15g of sodium hydroxide in 250mL of secondary water, Stir to combine well. Add the above iron salt solution and lye into the conical flask dropwise at room temperature, and continue stirring at a speed of 300 rpm for 2-6 hours, so as to facilitate the full reaction of the solution. Subsequent washing and centrifugation processes were the same as in Example 1.
Embodiment 3W
[0022] Cytotoxicity research of embodiment 3WSG-Fe3O4 particles
[0023] Cells were seeded in 96-well plates, cultured to 80% coverage, and the medium was aspirated. Add different concentrations of polypeptide-Fe3O4 particle suspension diluted with complete medium, 200μL / well, and culture for 24h, 48h, 72h. 4-6 parallel experiments in each experimental group, 2-3 repeated experiments, with polypeptide-Fe 3 o 4 The particle concentration was 0 group as a control. Add MTT solution at the detection time point, 20 μL / well (keep out of light), and incubate in a 37°C incubator for 24h. Aspirate the liquid in each well, add 150 μL / well dimethyl sulfoxide (DMSO), and incubate at 37° C. for 30 min. The absorbance was measured with a microplate reader at 490 nm.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 